MAPT and Alzheimer disease: Interesting applications of this methodology would be not only targeting the epigenetic profiling of neurons either in the vicinity of AD hallmarks (namely gliosis and amyloid plaques), or severely affected by tau pathology, but also assessing the differential epigenetic signatures of AD pathology spared neurons.